The patent US3876766 pertains to acarbose, an oral alpha-glucosidase inhibitor used to treat type 2 diabetes. This patent, originally filed by Bayer AG, covers the compound itself and its use in treating diabetes mellitus.
What is Acarbose Used For?
Acarbose works by slowing down the digestion of carbohydrates in the small intestine. This reduces the sharp rise in blood sugar levels after meals, helping to manage hyperglycemia in individuals with type 2 diabetes [1].
When Does the Acarbose Patent Expire?
Patent US3876766 has long since expired. U.S. patents generally have a term of 20 years from the filing date. Given the original filing date for patents of this era, this specific patent is no longer in effect, allowing for generic production of acarbose.
Who Manufactures Acarbose Today?
Following the expiration of key patents, numerous pharmaceutical companies now manufacture and market generic versions of acarbose. These include companies such as Teva Pharmaceuticals, Mylan N.V., and Aurobindo Pharma, among others [2]. Information on specific manufacturers and their products can often be found through pharmaceutical databases and drug information resources.
What Are the Side Effects of Acarbose?
Common side effects associated with acarbose treatment include gastrointestinal issues such as diarrhea, flatulence, and abdominal discomfort [1]. These side effects are related to the drug's mechanism of action, which involves the fermentation of undigested carbohydrates in the colon.
How Does Acarbose Compare to Other Diabetes Medications?
Acarbose is a monotherapy option and can also be used in combination with other oral antidiabetic agents, such as metformin or sulfonylureas. Unlike some other diabetes medications, acarbose does not typically cause weight gain or hypoglycemia when used alone [1]. Its primary benefit is the reduction of postprandial glucose excursions.
Can Generic Acarbose Be Prescribed?
Yes, generic versions of acarbose are widely available and prescribed by healthcare providers. The availability of generics typically leads to lower medication costs for patients and healthcare systems.
What Is the Mechanism of Action for Acarbose?
Acarbose inhibits alpha-glucosidase enzymes (such as sucrase, maltase, isomaltase, and glucoamylase) located in the brush border of the small intestine. By inhibiting these enzymes, acarbose delays the breakdown of complex carbohydrates into monosaccharides, thereby reducing glucose absorption into the bloodstream [1].
Are There Any Risks Associated with Acarbose?
While generally considered safe, acarbose carries risks, primarily gastrointestinal side effects. In rare cases, liver enzyme elevations have been reported. Patients with certain pre-existing conditions, such as inflammatory bowel disease or significant renal impairment, may not be suitable candidates for acarbose therapy [1].
Sources:
1. DrugPatentWatch.com
2. https://drugpatentwatch.com/